Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency.

MLA

Papan, Cihan, et al. “Beneficial IFN-α Treatment of Tumorous Herpes Simplex Blepharoconjunctivitis in Dedicator of Cytokinesis 8 Deficiency.” The Journal of Allergy and Clinical Immunology, vol. 133, no. 5, May 2014, pp. 1456–58. EBSCOhost, https://doi.org/10.1016/j.jaci.2014.02.008.

APA

Papan, C., Hagl, B., Heinz, V., Albert, M. H., Ehrt, O., Sawalle-Belohradsky, J., Neumann, J., Ries, M., Bufler, P., Wollenberg, A., & Renner, E. D. (2014). Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency. The Journal of Allergy and Clinical Immunology, 133(5), 1456–1458. https://doi.org/10.1016/j.jaci.2014.02.008

Chicago

Papan, Cihan, Beate Hagl, Valerie Heinz, Michael H Albert, Oliver Ehrt, Julie Sawalle-Belohradsky, Jens Neumann, et al. 2014. “Beneficial IFN-α Treatment of Tumorous Herpes Simplex Blepharoconjunctivitis in Dedicator of Cytokinesis 8 Deficiency.” The Journal of Allergy and Clinical Immunology 133 (5): 1456–58. doi:10.1016/j.jaci.2014.02.008.